R&D AI and the battle against AMR One of the largest threats facing public health is growing resistance to the world’s existing antibiotics.
News Rapid UTI tests could cut antibiotic resistance, says NICE Rapid urine tests could help NHS ensure that antibiotics are used appropriately.
Partner Content Partner Content Combating Antifungal Resistance to be discussed at Superbugs... Antifungal Resistance at Superbugs & Superdrugs 2019
Partner Content Partner Content Genentech develop Antibiotic with potential to lead to new c... Superbugs & Superdrugs 2019
Partner Content Partner Content WHO's Senior Advisor to speak at 21st Annual Superbugs &... WHO to speak at 21st Superbugs & Superdrugs 2019
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.